Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease
Sponsor: Healeon Medical Inc
Listed as NCT02952131, this PHASE1/PHASE2 trial focuses on Inflammatory Bowel Diseases and remains suspended. Sponsored by Healeon Medical Inc, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
12 versions recorded-
Oct 2024 — Present [monthly]
Suspended PHASE1/PHASE2
Status: Enrolling By Invitation → Suspended
-
Sep 2024 — Oct 2024 [monthly]
Enrolling By Invitation PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Enrolling By Invitation PHASE1_PHASE2
-
Jan 2021 — Sep 2022 [monthly]
Enrolling By Invitation PHASE1_PHASE2
▶ Show 7 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE1_PHASE2
Status: Recruiting → Enrolling By Invitation
-
Feb 2020 — Dec 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2018 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Dec 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Healeon Medical Inc
- Terry, Glenn C., M.D.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Stevensville, United States